• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Guideline on the diagnosis and treatment of stable coronary artery disease].

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Sep 24;46(9):680-694. doi: 10.3760/cma.j.issn.0253-3758.2018.09.004.

DOI:10.3760/cma.j.issn.0253-3758.2018.09.004
PMID:30293374
Abstract
摘要

相似文献

1
[Guideline on the diagnosis and treatment of stable coronary artery disease].[稳定型冠状动脉疾病诊断与治疗指南]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Sep 24;46(9):680-694. doi: 10.3760/cma.j.issn.0253-3758.2018.09.004.
2
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.2016年美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗时长的聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告：2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南、2011年美国心脏病学会基金会/美国心脏协会冠状动脉旁路移植手术指南、2012年美国心脏病学会/美国心脏协会/美国内科医师学会/美国胸外科医师协会/美国预防心脏病学会/心血管造影和介入学会/美国胸外科医师学会稳定型缺血性心脏病患者诊断和管理指南、2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南、2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南以及2014年美国心脏病学会/美国心脏协会非心脏手术患者围手术期心血管评估和管理指南的更新
Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29.
3
[Update on Current Care Guidelines. Current Care Guideline: Stable Coronary Artery Disease].[当前护理指南更新。当前护理指南：稳定型冠状动脉疾病]
Duodecim. 2015;131(10):967-8.
4
Correction to: 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guidelineon Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.对以下文献的勘误：《2016 ACC/AHA关于冠状动脉疾病患者双联抗血小板治疗时长的聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告：2011 ACCF/AHA/SCAI经皮冠状动脉介入治疗指南、2011 ACCF/AHA冠状动脉旁路移植手术指南、2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS稳定型缺血性心脏病患者诊断和管理指南、2013 ACCF/AHA ST段抬高型心肌梗死管理指南、2014 AHA/ACC非ST段抬高型急性冠状动脉综合征患者管理指南以及2014 ACC/AHA非心脏手术患者围手术期心血管评估和管理指南的更新》
Circulation. 2016 Sep 6;134(10):e192-4. doi: 10.1161/CIR.0000000000000452.
5
Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registry.加拿大稳定型冠状动脉疾病患者的特征和循证管理与世界其他地区的比较：来自 CLARIFY 登记研究的见解。
Can J Cardiol. 2014 Jan;30(1):132-7. doi: 10.1016/j.cjca.2013.07.680. Epub 2013 Nov 13.
6
Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry.法国稳定型冠状动脉疾病门诊患者的管理。来自稳定型冠状动脉疾病前瞻性观察纵向注册研究（CLARIFY）注册中心的研究结果。
Arch Cardiovasc Dis. 2014 Aug-Sep;107(8-9):452-61. doi: 10.1016/j.acvd.2014.06.001. Epub 2014 Aug 13.
7
Achievement of guideline-concordant care and in-hospital outcomes in patients with coronary artery disease in teaching and nonteaching hospitals: results from the Get With The Guidelines-Coronary Artery Disease program.教学医院和非教学医院中冠心病患者遵循指南治疗的达成情况及院内结局：来自“遵循冠心病指南”项目的结果
Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):58-65. doi: 10.1161/CIRCOUTCOMES.112.965525. Epub 2012 Dec 11.
8
Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.稳定型冠状动脉疾病的治疗决策：来自欧洲冠状动脉血运重建调查的见解
J Thorac Cardiovasc Surg. 2006 Nov;132(5):1001-9. doi: 10.1016/j.jtcvs.2006.05.051.
9
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).在有记录的冠心病患者中，经皮冠状动脉介入治疗、冠状动脉旁路移植术与单纯药物治疗（来自REACH国际注册研究）的指南推荐疗法比较。
Am J Cardiol. 2007 May 1;99(9):1212-5. doi: 10.1016/j.amjcard.2006.12.039. Epub 2007 Mar 16.
10
[Acceptance and practicability of a guideline for rehabilitation in coronary artery disease].[冠状动脉疾病康复指南的接受度与实用性]
Rehabilitation (Stuttg). 2006 Aug;45(4):203-12. doi: 10.1055/s-2005-915461.

引用本文的文献

1
Effects of Additional Chinese Herbal Medicines Treatment in Patients with Type 2 Diabetes Mellitus Combined with Stable Angina Pectoris: A Retrospective Cohort Study.加用中药治疗对2型糖尿病合并稳定型心绞痛患者的影响：一项回顾性队列研究
Diabetes Metab Syndr Obes. 2025 Aug 31;18:3135-3148. doi: 10.2147/DMSO.S541164. eCollection 2025.
2
Bioinformatic analyses and validated experiments reveal an aging hallmark gene set and protective miR of coronary artery disease.生物信息学分析和验证实验揭示了一组冠状动脉疾病的衰老标志基因和保护性miRNA。
Sci Rep. 2025 Sep 1;15(1):32102. doi: 10.1038/s41598-025-17668-w.
3
Predictive value of serum myeloperoxidase (MPO) concentration combined with triglyceride-glucose index (TyG) for major adverse cardiaovascular events (MACE) in patients with coronary heart disease.
血清髓过氧化物酶（MPO）浓度联合甘油三酯-葡萄糖指数（TyG）对冠心病患者主要不良心血管事件（MACE）的预测价值
Int J Cardiol Cardiovasc Risk Prev. 2025 Aug 10;27:200490. doi: 10.1016/j.ijcrp.2025.200490. eCollection 2025 Dec.
4
Predicting the occurrence of probable sarcopenia in middle-aged and elderly patients with coronary artery disease: development and validation of a clinical model.预测中老年冠心病患者可能发生的肌肉减少症：一种临床模型的建立与验证
Sci Rep. 2025 Aug 6;15(1):28830. doi: 10.1038/s41598-025-13712-x.
5
Impact of China's National Volume-Based Drug Procurement: A Multilevel Interrupted Time Series Analysis on Medical Expenditures in Hypertensive Patients.中国国家药品集中采购的影响：对高血压患者医疗支出的多层次中断时间序列分析
Int J Health Policy Manag. 2025;14:8540. doi: 10.34172/ijhpm.8540. Epub 2025 May 25.
6
Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 Update.《2025年东亚冠状动脉疾病患者抗血小板治疗立场声明更新版》
JACC Asia. 2025 Jul;5(7):821-846. doi: 10.1016/j.jacasi.2025.04.010.
7
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024.《2024年中国心力衰竭诊断和治疗指南》
J Geriatr Cardiol. 2025 Mar 28;22(3):277-331. doi: 10.26599/1671-5411.2025.03.002.
8
Dietary Patterns Associated With Heat Retention in Blood Vessel Syndrome (HRBVS) in Coronary Heart Disease: A Cross-Sectional Study.冠心病血管综合征（HRBVS）中与热潴留相关的饮食模式：一项横断面研究。
Int J Gen Med. 2025 Mar 5;18:1283-1294. doi: 10.2147/IJGM.S510507. eCollection 2025.
9
Construction and Verification of a Frailty Risk Prediction Model for Elderly Patients with Coronary Heart Disease Based on a Machine Learning Algorithm.基于机器学习算法的老年冠心病患者衰弱风险预测模型的构建与验证
Rev Cardiovasc Med. 2025 Feb 21;26(2):26225. doi: 10.31083/RCM26225. eCollection 2025 Feb.
10
Establishing and internally validating a predictive model for coronary heart disease incorporating triglyceride-glucose index, monocyte-to-high-density lipoprotein cholesterol ratio and conventional risk factors in patients experiencing chest pain and referred for invasive coronary angiography.建立并在内部验证一个针对冠心病的预测模型，该模型纳入了甘油三酯-葡萄糖指数、单核细胞与高密度脂蛋白胆固醇比值以及常规风险因素，用于因胸痛而接受有创冠状动脉造影的患者。
Lipids Health Dis. 2025 Feb 25;24(1):72. doi: 10.1186/s12944-025-02486-w.